News Archive

• Epoprostenol PH&T received Marketing Authorization
• PH&T and STADA Asia announce their agreement for Latanoprost and Alfuzosin
• Exemestane significantly reduces risk of breast cancer
• Latanoprost showed full therapeutical equivalence
• Zydus Cadila succesfully launched Turbospin licensed by PH&T
• Alfuzosin PH&T 10 mg. prolonged release tablets has been registered in Philippines by STADA
• Somatostatin PH&T Vietnam
• PH&T at CPhI 2010
• Exemestane PH&T proved bioequivalent to Aromasin (Pfizer)
• READ MORE NEWS